American Thoracic Society

Type: Organization
Name: American Thoracic Society
First reported Jul 21 2014 - Updated Jul 22 2014 - 1 reports

IPF grabs headlines at American Thoracic Society conference

ATS 2014 conference was held in California, next year it will be DenverJust prior to landing in San Diego it was somewhat disconcerting to see fire spreading across the terrain and huge patches of scorched earth, as the county witnessed a dramatic wildfire ... [Published Pharmafocus - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

UA-Led School Asthma Program Receives National Recognition

A school-based asthma program led by the University of Arizona Mel and Enid Zuckerman College of Public Health in Tucson is receiving national attention.The program provides standing orders that allow schools to stock albuterol and administer it to students ... [Published University of Arizona - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Amish lifestyle may reduce likelihood of asthma, study says

Does the Amish lifestyle reduce the risk of asthma?It’s a real possibility, according to a recent study conducted by two Franklin & Marshall College researchers and others.“All we have is a hint that Amish women have less asthma than other women in Central ... [Published Lancaster Online - Jul 21 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Comparison of British Thoracic Society and American Thoracic Society reintroduction guidelines for anti-tuberculous therapy induced liver injury

AbstractObjective: To compare the efficacy of British Thoracic Society and American Thoracic Society guidelines for re-introduction of anti-tuberculous therapy after drug-induced liver injury, and to assess the ease of administration of each guideline ... [Published JPMA - Jul 18 2014]
First reported Jul 17 2014 - Updated Jul 18 2014 - 1 reports

BI’s ‘breakthrough’ treatment for idiopathic pulmonary fibrosis may delay lung function loss

Boehringer Ingelheim Pharmaceuticals Inc, part ofGerman pharmaceutical group Boehringer Ingelheim, said Wednesdaythat the US FDA had granted Breakthrough Therapy status to itstyrosine kinase inhibitor (TKI), nintedanib, as a therapy ofidiopathic pulmonary ... [Published MedCity News - Jul 17 2014]
First reported Jul 16 2014 - Updated Jul 17 2014 - 6 reports

US “Breakthrough” designation in IPF for Boehringer’s nintedanib

The US Food and Drug Administration has granted Breakthrough Therapy designation for German family-owned pharma major Boehringer Ingelheim’s nintedanib, a treatment in idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.Nintedanib ... [Published Pharma Letter - Jul 17 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

E-Cigarettes Should Be Banned: Health Groups

Governments should ban or limit the use of electronic cigarettes until more is known about their health effects, say experts from the world's leading lung organizations.The position statement was issued Wednesday by the Forum of International Respiratory ... [Published NewsMax.com - Jul 10 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

World's Leading Lung Societies Release Position Statement on E-Cigarettes

Contact InformationAvailable for logged-in reporters onlyNewswise — Experts from the world’s leading lung organizations have released a position statement on electronic cigarettes, focusing on their potential adverse effects on human health and calling ... [Published Newswise - Jul 10 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

RWJF’s Work to Make Minority Medical Faculty a Priority

Directors at the National Institutes of Health, medical school deans and presidents, professors, members of the Institute of Medicine and the National Academy of Sciences—these are just a few examples of the impressive roles that Harold Amos Medical Faculty ... [Published RWJF - Jun 26 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

New ATS Standards Spur Spirometer Upgrades from Benson Medical

Minneapolis, MN- Back in the year 2000, many occupational health nurses upgraded their spirometry equipment to hand-held or stand-alone instruments. In 2005, the American Thoracic Society revised their spirometer standards with regard to accuracy and ... [Published Advance for Respiratory Care & Sleep Medicine - Jun 25 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Time to Move Forward With Lung Screening

By James L. Mulshine, MDJune 25, 2014, Volume 5, Issue 10Figures:James L. Mulshine, MD“To respect the lives of people who will soon be developing lung cancer and to respect the investment of U.S. citizens who funded the massive National Lung Screening ... [Published The ASCO Post - Jun 25 2014]
First reported May 16 2014 - Updated May 16 2014 - 3 reports

Forest Laboratories, Inc. to Present Data about Aclidinium, Aclidinium/Formoterol Combination, and Roflumilast at the American Thoracic Society International Conference

NEW YORK--(EON: Enhanced Online News)--Forest Laboratories, Inc. (NYSE:FRX) today announced that it will present data on aclidinium, aclidinium/formoterol combination, and roflumilast at the American Thoracic Society (ATS) 2014 International Conference ... [Published EON Science - May 16 2014]

Quotes

"We expect that the stock albuterol program and standing orders will reduce asthma-related morbidity outcomes such as 911 calls due to asthma, the number of children sent home due to asthma, asthma-related absences and class time missed due to time spent in the health office for asthma symptoms" said Lynn B Gerald , professor of health promotion sciences at the College of Public Health and the Canyon Ranch Endowed Chair
...Chief Executive Officer of the CPF, a non-profit foundation and patient advocacy group for patients and families suffering from the disease. "It has been a long time coming for patients and families who have witnessed many failed clinical trials to date. We are hopeful that patients will finally have access to a treatment here in the U S "
...for patients with IPF," said Sabine Luik, M D , senior vice president, Medicine & Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. "We are committed to working with the FDA during the NDA review of nintedanib for people living with this serious and life-threatening lung disease, for which there are currently no FDA-approved treatment options."
"We're excited nintedanib* has been granted breakthrough therapy designation in the US, which we hope will make the treatment available to IPF patients as quickly as possible. Currently there are no FDA-approved treatments available for IPF. We are committed to working with all regulatory bodies to make nintedanib* available to people living with this serious and life-threatening lung disease." said Professor Klaus Dugi, Chief Medical Officer, Boehringer Ingelheim

More Content

All (142) | News (82) | Reports (0) | Blogs (54) | Audio/Video (0) | Fact Sheets (0) | Press Releases (6)
sort by: Date | Relevance
Site of eosinophilic inflammation important in ... [Published MedWire News - Jul 22 2014]
UA-Led School Asthma Program Receives National ... [Published University of Arizona - Jul 21 2014]
Amish lifestyle may reduce likelihood of asthma... [Published Lancaster Online - Jul 21 2014]
IPF grabs headlines at American Thoracic Societ... [Published Pharmafocus - Jul 21 2014]
Lung societies advise restriction, ban on e-cig... [Published Orthopedics Today - Jul 20 2014]
Stars aligning for U.S. Patients Suffering from... [Published Benzinga.com - Jul 18 2014]
Comparison of British Thoracic Society and Amer... [Published JPMA - Jul 18 2014]
Boehringer Ingelheim receives breakthrough ther... [Published Individual.com - Jul 18 2014]
Prevention and Management of Respiratory Viruses [Published U.S.Pharmacist - Jul 17 2014]
BI’s ‘breakthrough’ treatment for idiopathic pu... [Published MedCity News - Jul 17 2014]
US “Breakthrough” designation in IPF for Boehri... [Published Pharma Letter - Jul 17 2014]
Boehringer Ingelheim's investigational therapy ... [Published Pharmacy Choice - Jul 17 2014]
FDA grants Breakthrough Therapy designation to ... [Published News-Medical.Net - Jul 17 2014]
Boehringer Ingelheim’s investigational therapy ... [Published Business Wire - Jul 17 2014]
Boehringer Ingelheim’s investigational therapy ... [Published Boehringer Ingelheim - Jul 17 2014]
Late Night: Two More Reasons to Reschedule Mari... [Published Firedoglake - Jul 17 2014]
Pulmonary Abnormalities in HIV+ Patients Treate... [Published General Medicine eJournal - Jul 17 2014]
Rheumatoid Arthritis and Lung Disease: A Practi... [Published General Medicine eJournal - Jul 17 2014]
Boehringer Ingelheim's Investigational Therapy ... [Published Bio-Medicine - Jul 16 2014]
Boehringer awaits FDA approval of lung fibrosis... [Published Connecticut Post - Jul 14 2014]
Mustaches may raise burn risk with home oxygen ... [Published Yahoo! News - Jul 11 2014]
Grapefruit, Banana, And Cheese Could Conquer Lu... [Published Advance for Respiratory Care & Sleep Medicine - Jul 11 2014]
E-Cigarettes Should Be Banned: Health Groups [Published NewsMax.com - Jul 10 2014]
U.S. FDA Accepts NDA Filing for Boehringer Inge... [Published Drugs.com - Jul 10 2014]
World's Leading Lung Societies Release Position... [Published Newswise - Jul 10 2014]
Theravance, Inc. Appoints Theodore J. Witek, Jr... [Published 4 Traders - Jul 10 2014]
$800,000 for Medical Records Dumping [Published Advance for Respiratory Care & Sleep Medicine - Jul 09 2014]
Abnormal Lung Function in Recent Veterans Raise... [Published US Medicine - Jul 08 2014]
Pacific Therapeutics gets European fibrosis dru... [Published Stockwatch - Jul 07 2014]
Theravance appoints SVP of corporate partnershi... [Published Individual.com - Jul 07 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Late Night: Two More Reasons to Reschedule Mari... [Published Firedoglake - Jul 17 2014]
cross posted at mlaw Part 1 More medical evidence demonstrates why the USA must reschedule cannabis. Scientists in England are reporting what could be a significant breakthrough in the treatment of all forms of cancer stating that their research ...
A Step Toward Cleaner Air and Healthier Communi... [Published White House.gov Blog Feed - Jun 11 2014]
Last week, the Environmental Protection Agency released a vital component of the President’s Climate Action Plan – proposed common-sense carbon pollution standards for existing power plants. Since air pollution from power plants can worsen asthma and ...
Coal Lobby Isolated by Broad Support for Carbon... [Published Switchboard, from NRDC - Jun 05 2014]
Pete Altman, Climate and Clean Air Campaign Director, Washington, D.C. Support for the President’s Climate Plan and the Environmental Protection Agency’s proposal to set the first-ever limits on carbon pollution from power plants is pouring in from ...
EPA's Clean Power Plan: A Breath of Fresh Air f... [Published Switchboard, from NRDC - Jun 03 2014]
Kim Knowlton, Senior Scientist, New York This is a historic week for the health of the American people, and our future generations. The Obama administration announced yesterday its Clean Power Plan proposal for working with states to set national ...
[News] 2014 American Thoracic Society Internati... [Published The Lancet Respiratory Medicine online - May 29 2014]
Results of two trials of nintedanib offer new hope for people with idiopathic pulmonary fibrosis (IPF). “The drug is a small molecule tyrosine-kinase inhibitor, and in particular the drug is targeting three tyrosine kinases, which are called the vascular ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Experts to Discuss Data from Three IPF Trials o... [Published GlobeNewswire: Acquisitions News - May 23 2014]
Pulmonary Fibrosis Experts to Address Positive ... [Published GlobeNewswire: Advertising News - May 22 2014]
Continuing progress in accelerating late stage ... [Published AstraZeneca - May 15 2014]
Corrected - Aquinox Pharmaceuticals Announces P... [Published GlobeNewswire: Acquisitions News - May 15 2014]
Aquinox Pharmaceuticals Announces Presentation ... [Published GlobeNewswire: Acquisitions News - May 14 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.